This website uses cookies to provide you with the best possible user experience. We log, strictly anonymously, your user behaviour in order to identify important topics for visitors and to detect any malfunctions that may occur. For more information and to opt out of tracking, please see our Privacy Policy.

Hemophilia - What are the potentials of antibody and gene therapies?

Tue, 2019 / 01 / 22
On February 21st, 2019, the symposium "Hemophilia Care Control" organized by the organization FORUM will take place in Berlin. The core topic will be health care management for hemophilia drugs.

The symposium starts with a lecture by conference leader Prof. Matthias P. Schönermark, M.D., Ph.D. regarding the topic "Current developments in the field of hemophilia". Prof. Schönermark will speak about modern therapy methods, like antibody and gene therapies, and their ethical and economic consequences. Afterwards, further lectures and discussion rounds of different speakers will follow.

The self-imposed goal of the symposium is it to stimulate the exchange between advisers and participants among themselves. Accordingly, a lot of time will be available for interaction with the speakers.

Prof. Matthias P. Schönermark, M.D., Ph.D. is the managing director of SKC consulting. SKC's highest priority is to take care of its clients' needs and concerns.
to the top